StockNews.com assumed coverage on shares of Milestone Scientific (NYSE:MLSS – Get Free Report) in a research note issued on Wednesday. The brokerage set a “hold” rating on the stock.
Milestone Scientific Stock Performance
Shares of MLSS opened at $0.57 on Wednesday. Milestone Scientific has a 1 year low of $0.52 and a 1 year high of $1.35. The company has a market cap of $43.66 million, a price-to-earnings ratio of -5.70 and a beta of 0.97. The firm has a fifty day moving average of $0.65 and a 200-day moving average of $0.70.
Milestone Scientific (NYSE:MLSS – Get Free Report) last issued its quarterly earnings data on Friday, March 29th. The company reported ($0.03) earnings per share for the quarter. Milestone Scientific had a negative net margin of 70.50% and a negative return on equity of 86.72%. The company had revenue of $2.26 million for the quarter.
Institutional Trading of Milestone Scientific
About Milestone Scientific
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
See Also
- Five stocks we like better than Milestone Scientific
- Where Do I Find 52-Week Highs and Lows?
- Hasbro’s Management Made All the Right Calls This Quarter
- How to Invest in Insurance Companies: A Guide
- Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower Prices
- Breakout Stocks: What They Are and How to Identify Them
- Power Surge: Utilities Sector’s Resilience Shines
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.